148
Views
23
CrossRef citations to date
0
Altmetric
PCOS

Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome

, , , , , , , & show all
Pages 637-643 | Received 17 Apr 2008, Accepted 14 Jul 2008, Published online: 07 Jul 2009

References

  • Asunción M, Calvo R M, San Millán J L, Sancho J, Avila S, Escobar-Morreale H F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434–2438
  • Knochenhauer E S, Key T J, Kahsar-Miller M, Waggoner W, Boots L R, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078–3082
  • Stein I F, Leventhal M L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–191
  • Kousta E, Tolis G, Franks S. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens) 2005; 4: 133–147
  • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774–800
  • Venkatesan A M, Dunaif A, Corbould A. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res 2001; 56: 295–308
  • Goodarzi M O, Korenman S G. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 2003; 80: 255–258
  • De Fronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223
  • Gennarelli G, Rovei V, Novi R F, Holte J, Bongioanni F, Revelli A, Pacini G, Cavallo-Perin P, Massobrio M. Preserved insulin sensitivity and β-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 3381–3386
  • Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 2586–2593
  • Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 1994; 78: 1052–1058
  • Arslanian S A, Lewy V D, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 66–71
  • Ciampelli M, Fulghesu A M, Cucinelli F, Pavone V, Caruso A, Mancuso S, Lanzone A. Heterogeneity in β cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 1997; 12: 1897–1901
  • Rodin D A, Bano G, Bland J M, Taylor K, Nussey S S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 1998; 49: 91–99
  • Norman R J, Mahabeer S, Masters S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril 1995; 63: 58–62
  • Ganie M A, ML Khurana, Eunice M, Gupta N, Diwedi S N, Gulati M S, Ammini A C. Prevalence of glucose intolerance among adolescent and young women with polycystic ovary syndrome in India. Indian J Endocrinol Metab 2004; 6: 9–13
  • Ganie M A, Khurana M L, Eunice M, Gupta N, Gulati M, Dwivedi S N, Ammini A C. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab 2004; 89: 2756–2762, Erratum in: J Clin Endocrinol Metab 2004;89:4655
  • Snehalatha C, Ramachandran A, Vijay V, Viswanathan M. Differences in plasma insulin responses in urban and rural Indians. Diabet Med 1994; 11: 445–448
  • Mohan V, Sharp P S, Cloke H R, Burrin J M, Schumer B, Kohner E M. Serum immunoreactive insulin response to a glucose load in Asian Indian and European type 2 diabetic patients and control subjects. Diabetologia 1986; 29: 235–237
  • Douglas C C, Norris L E, Oster R A, Darnell B E, Azziz R, Gower B A. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril 2006; 86: 411–417
  • Kauffman R P, Baker V M, Dimarino P, Gimpel T, Castracane V D. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002; 187: 1362–1369
  • Carmina E, Lobo R A. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004; 82: 661–665
  • Ramachandran A. Diabetes & obesity – the Indian angle. Indian J Med Res 2004; 120: 437–439
  • Anjana M, Sandeep S, Deepa R, Vimaleswaran K S, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 2004; 27: 2948–2953
  • Vikram N K, Pandey R M, Misra A, Sharma R, Devi J R, Khanna N. Non-obese (body mass index <25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 2003; 19: 503–509
  • Reddy K S, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596–601
  • King H, Aubert R E, Herman W H. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414–1431
  • Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26: 1380–1384
  • Misra A, Vikram N K. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002; 83(12)
  • Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217–230
  • Philip J. Profile of recently diagnosed type 2 diabetics attending a tertiary care hospital in north India. Thesis. All India Institute of Medical Sciences, New Delhi 2006
  • Ehrmann D A, Barnes R B, Rosenfield R L, Cavaghan M K, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–146
  • Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson P O, Mattson L A, Crona N, Lundberg P A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505–513
  • Yildiz B O, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2031–2036
  • Colilla S, Cox N J, Ehrmann D A. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first-degree relatives. J Clin Endocrinol Metab 2001; 86: 2027–2031
  • Legro R S, Bentley- Lewis R, Driscoll D, Wang S C, Dunaif A. insulin resistance in sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 2002; 87: 2128–2133
  • Goodarzi M O, Erickson S, Port S C, Jennrich R I, Korenman S G. β-Cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 310–315
  • Maliqueo M, Atwater I, Lahsen R, Pérez-Bravo F, Angel B, Sir-Petermann T. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of β-cell dysfunction. Hum Reprod 2003; 18: 2683–2688
  • Dunaif A, Finegood D T. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 942–947
  • Ehrmann D A, Sturis J, Byrne M M, Karrison T, Rosenfield R L, Polonsky K S. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995; 96: 520–527
  • Legro R S, Kunselman A R, Dodson W C, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165–169
  • Corbould A, Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 2007; 56: 716–722
  • Bergman R N. Toward physiologic understanding of glucose tolerance. Minimal model approach. Diabetes 1989; 38: 1512–1527
  • Porte D, Jr. β Cells in type II diabetes. Diabetes 1991; 40: 166–180
  • Bock G, Man D G, Campioni M, Chittiilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Pathogenesis of pre-diabetes. Mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006; 55: 3536–3549
  • Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–1174
  • Eliasson B, Björnsson E, Urbanavicius V, Andersson H, Fowelin J, Attvall S, Abrahamsson H, Smith U. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia 1995; 38: 79–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.